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M1ABSTRACT
Objective: To investigate the correlation between activation of toll-like receptors 3 (TLR3)
signaling pathway and tumor-associated macrophage and its effect on the tumor growth.
Methods: The mice Lewis lung cancer cell lines 3LL and melanoma B16H10 were used
to construct the subcutaneous transplantation tumor models and then they were treated
with Poly-ICLC. The curative effect was observed and then the T cell and macrophage
phenotypes inﬁltrated in local tumor were detected by ﬂow cytometry. After the in vitro
culture of mouse bone marrow-derived macrophage, the real-time PCR and western blot
were applied to detect the expression of macrophage activation markers and the activation
of intracellular signaling pathways.
Results: The survival time of mice with brown tumor treated with Poly-ICLC signiﬁ-
cantly increased and the tumor growth was inhibited. The ratio of local tumor-inﬁltrated
Treg decreased, while the ratio of CD8+ T cell increased signiﬁcantly. The macrophages
surface CD206 expression was down-regulated while the expression of iNOS increased.
The Poly-ICLC could promote the expression of M1 markers (IL-1b, TNF-a and iNOS)
in bone marrow-derived macrophage and inhibited the expression of M2 molecules (Arg-
1, YM-1 and CD206). The phosphorylation level of downstream p65, TBK1 and IRF3
increased signiﬁcantly.
Conclusions: The Poly-ICLC can activate the TLR3 downstream signaling pathway to
induce a M1 polarization of tumor associated macrophage, thereby inhibiting the tumor
growth.1. Introduction
The tumor associated macrophages (TAM) refer to a kind of
macrophages which are migrated and inﬁltrated in local tumor
during the occurrence and development of tumor, and can be
brought together with other immune cells, tumor cells, ﬁbro-
blast and interstitial cytokines to form a tumor immune
microenvironment. The TAM can secrete a variety of cytokines
and inﬂammatory mediators which play a key role in the for-
mation of tumor microenvironment and tumor invasion and
metastasis. According to the activation type of macrophage, it
can be divided to two main types M1 and M2. The M1 has the
anti-tumor effect which can be exerted by secreting theproinﬂammatory factor, while M2 can promote the growth,
invasion and metastasis of tumor through the expression
of immune inhibitory signal molecule [1]. The function of M1
and M2 macrophages is entirely different in the tumor
microenvironment. The clinical data have showed that M2
TAM can inﬁltrate in a wide variety of tumors and the
inﬁltration number is negatively correlated with the prognosis
of patients [2–5]. Therefore, the regulation and control of M2
TAM can be a key factor for improving the prognosis of
tumor. This paper aims to investigate the effect of Poly-ICLC
on the macrophage polarization and tumor growth.
2. Materials and methods
2.1. Main reagents
The RT-PCR primer was designed and synthesized by
Shanghai Sangon Biotechnology Company. The RT-PCR kit
and the ordinary PCR kit were purchased from the Takara
Company. The mice Lewis lung cancer cell line 3LL and therticle under the CC BY-NC-ND license (http://
Table 1
The sequence of real-time PCR primer.
Gene name Primer sequences
IL-1b-F 50-AAGCCTCGTGCTGTCGGACC-30
IL-1b-R 50-TGAGGCCCAAGGCCACAGGT-30
TNFa-F 50-CATCTTCTCAAAATTCGAGTGACAA -30
TNFa-R 50-CCAGCTGCTzCCTCCACTTG-30
iNOS-F 50-GTTCTCAGCCCAACAATACAA-30
iNOS-R 50-GTGGACGGGTCGATGTCAC-30
Arg-1-F 50-TGGCTTGCGAGACGTAGAC-30
Arg-1-R 50-GCTCAGGTGAATCGGCCTTTT-30
YM-1-F 50-AGAAGGGAGTTTCAAACCTGGT-30
YM-1-R 50-CTCTTGCTGATGTGTGTAAGTGA-30
CD206-F 50-TTCGGTGGACTGTGGACGAGC A-30
CD206-R 50-ATAAGCCACCTGCCACTCCGG T-30
b-actin-F CGTGAAAAGACCCAGATCA
b-actin-R CACAGCCTGGATGGCTACGT
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was purchased from Invitrogen. The DMEM Medium (high
glucose), antibiotics, L-glutamine and the fetal calf serum were
purchased from Gibco. The protease inhibitor and phosphatase
inhibitors were collected from Roche. For the use of western
blot, the p-p65 (S536), p-TBK1 (S172), p-IRF3 (S396) primary
antibodies and horseradish peroxidase-labeled secondary anti-
bodies were bought from CST. The CD45, CD3, CD4, CD8,
Foxp3, CD206, F4/80 and iNOS for ﬂow cytometry were all
purchased from eBioscience.
2.2. Animal model
All the animals involved in this study were purchased from
the Chongqing Medical University Laboratory Animal Center
(C57 mice, clean, 8 weeks old and weighing 20 g). The collected
cells were digested by using the pancreatic enzymes and the ﬁnal
concentration was adjusted at 1 × 107/mL. After that, the treated
cells were placed in the ice until use. The mice were narcotized
with 200 L of 0.75% sodium pentobarbital solution per mouse
and then were conducted to an inguinal subcutaneous injection
of 5 × 105 tumor cells. The mice in treating group were then
received an intraperitoneal injection of 50 mg Poly-ICLC at 5th
day after the model construction, and a drug administration
every other day for four times was conducted. While the mice in
control group were also received the same volume injection of
PBS and then the tumor size was calculated. The experiment was
approved by the Biomedical Ethics Committee of Chongqing
Medical University.
2.3. Cell cultivation
The cultivation of mice Lewis lung cancer cell line 3LL and
melanoma B16H10 cell was conducted in the DMEM medium
contained 10% fetal calf serum, 1% double resistant and 2 mM
L-glutamine. Then the cultivated cells were stored in the incu-
bator with 5% CO2, saturated humidity and at 37 C for culti-
vation. The medium was replaced every 2–3 d and the cells were
not transferred to a conventional cultivation until the cell density
was moderate. The in vitro macrophage cultivation was carried
out by using the mouse bone marrow, and after that the BALB/c
mice were conducted to death by broken neck dislocation and
75% alcohol disinfection, the bilateral tibioﬁbula was obtained
under the aseptic condition. Then the distal insertion of a syringe
needle (5 mL injector) contained with 1 mL DMEM was con-
ducted. The DMEM was injected to get the bone marrow cell,
and then the collected cells were placed in sterile tube to a
repeated stir until that the cells distributed evenly. Then using
the ACK to crack red cells and they were ﬁltered by a 200-mesh
sieve. After washing by DMEM for 2 times, the cells were
resuspended by using L929 cell-conditioned medium (contained
with 30% L929 cell 3-d cultured supernatant) and then were
inoculated in a petri dish. After 7 d, the adherent cells were
removed and the remaining cells were the bone marrow-derived
macrophage.
2.4. Flow cytometry
The single-cell suspension of local tumor tissue was obtained
from the collagen digestion and after the isolation by Percol, the
mononuclear cell was obtained. The steps for surface antigenstaining were conducted strictly in accordance with the Best
Protocol (eBioscience). At ﬁrst, they were blocked by using the
CD16/32 antibody for 10 min at 4 C and after that, were
washed by PBS to obtain 300 mL PBS heavy suspension.
Finally, they were conducted to a detection by using BD ﬂow
cytometry. The data were analyzed and drawned by applying the
FlowJo software.
2.5. Real-time PCR
After cell collection, the total RNA was extracted by trizol
method and was dissolved in 20 mL DEPC treating water. Then
the concentration of total RNA was detected by using Nano-
Drop (Thermo, American). The reverse transcription system
had 20 mL materials and after adding in 1.5 mg total RNA, they
were removed the genomic DNA by using RT-PCR Kit
(Takara) and then were conducted to a reverse transcriptional
reaction according to the manual operation steps. The obtained
reverse transcripts were diluted 10 times and subsequently
conducted to a real-time PCR ampliﬁcation by using real-time
qPCR (ABI 7500, American) and SYBR Green kit (Takara).
With the b-actin as a reference, the relative gene expression
level was calculated by using 2−DDCt method. The primers were
synthesized by Shanghai Sangon Biotechnology Company
(Table 1).
2.6. Western blot
The macrophage was processed by using 100 ng/mL of
Poly-ICLC for 30 min, and after 1 h, the cells were collected.
The precooling PBS, after washing, were conducted to a cell
lysis by using lysis buffer contained with 1 M tris–HCl pH
7.5, 1% TritonX-100, 1% NP-40, 10% SDS, 0.5% sodium
deoxycholate, 0.5 M EDTA, 10 mg/mL leupeptin, 10 mg/mL
aprotinin, 1 mM PMSF, 40 mmol/L DTT, phosphatase in-
hibitors and protease inhibitor. After centrifugation at 4 C
12000 r/min for 20 min, the supernatant was collected and
then tested by Bradford method. The total protein was boiled
for 10 min for the denaturation, and the electrophoretic sep-
aration and transmembrane of it were then carried out in the
SDS-PAGE gel. The PVDF membrane was blocked in tris
buffered saline Tween (TBST) of 5% skimmed milk powder
for 2 h and then added in primary antibodies for overnight
Table 3
The inﬁltration of Treg and CD8+ T cells in the local tumor.
Ratio/CD45+(%) PBS group Poly-ICLC group
Treg 21.38 ± 4.76 9.14 ± 2.06*
CD8+ T cell 19.95 ± 5.31 38.97 ± 6.55*
Compared with the control group, *P < 0.05.
Table 4
Expression of M1/M2 type markers in the macrophage.
M1/M2 markers (%) PBS group Poly-ICLC group
CD206 48.62 ± 9.62 17.57 ± 7.13*
iNOS 2.67 ± 0.48 6.03 ± 2.75*
Compared with the control group, *P < 0.05.
Table 5
Bo Liu et al./Asian Paciﬁc Journal of Tropical Medicine 2016; 9(5): 484–488486incubation at 4 C. After the TBST was washed for 5 min for 3
times, the second antibody (horseradish peroxidase labeled
goat anti rabbit IgG, 1:1000) was added in and then was
incubated at room temperature for 2 h. When the sufﬁcient
rinse of TBST for 10 min for total 3 times was ﬁnished, the
coloration was carried out by using electrochemiluminescence
method.
2.7. Statistical analysis
All the experimental data were processed by using GraphPad
Prism software and were showed as Mean ± SE. The analysis of
the survival curves was tested by applying the Long-Rank. The
Means of two groups were tested by using t-test and P < 0.05
was considered statistically signiﬁcant.
3. Results
3.1. Signiﬁcant inhibition of tumor growth by Poly-ICLC
In the subcutaneous tumor animal models of 3LL and
B16F10, the tumor growth ratio of mice in Poly-ICLC treating
group signiﬁcantly decreased and the survival time of mice with
brown tumor was signiﬁcantly longer than that in PBS control
group with that the tumor size also had signiﬁcant difference
between two groups after 15-d growth of brown tumor (Table 2),
which showed that the Poly-ICLC could inhibit the tumor
growth.
3.2. Increase of CD8+ T cell ratio and the decrease of
Treg (CD3+)
In order to deﬁne the mechanism of Poly-ICLC on inhibiting
tumor growth, the inﬁltration of local tumor T cell was detected
by using ﬂow cytometry. The result showed that compared with
control group, the ratio of Treg of local tumor in mice with
brown tumor in treating group notably decreased among the
CD45+CD3+ cells, while the ratio of CD8+ T cell increased
signiﬁcantly, there were signiﬁcant difference between them
(Table 3).
3.3. Changes of macrophage phenotypes
Meanwhile, the signiﬁcant difference was also found in the
expression of M1 and M2 macrophage phenotypes in local tu-
mor. Compared with the PBS group, the expression of CD206
(M2-type markers) in macrophage (CD45+F4/80+ cells) in
treating group was signiﬁcantly inhibited, while, the expression
of iNOS (M1-type markers) increased markedly (Table 4). The
results revealed that Poly-ICLC could improve the tumor im-
mune microenvironment.Table 2
The effect of Poly-ICLC on tumor growth.
Group PBS group Poly-ICLC group
3LL Tumor size (mm2) 82.73 ± 6.21 48.91 ± 7.32*
Survival time (d) 21.21 ± 1.32 28.77 ± 2.19*
B16F10 Tumor size (mm2) 79.13 ± 8.03 42.10 ± 6.52*
Survival time (d) 20.62 ± 2.41 32.51 ± 3.81*
Compared with PBS group, *P < 0.05.3.4. M1 macrophage polarization induced by Poly-ICLC
The Poly-ICLC was used to in vitro processed the bone
marrow-derived macrophage and after 24 h, the changes of the
expression of M1/M2 markers were detected by real-time PCR.
As shown in Table 5, the expression of M1 polarization genes
iNOS, TNF-a and IL-1b of cells treated with Poly-ICLC in-
creases signiﬁcantly compared with the control group, while the
expression of M2 type markers CD206, YM-1 and Arg-1 de-
creases notably and there is a concentration dependence.
3.5. Activation of toll-like receptors 3 (TLR3)
downstream signaling pathways by Poly-ICLC
In order to further discuss the forming pattern of macrophage
M1 polarization induced by Poly-ICLC, the TLR3 downstream
signaling pathway was tested and the result showed that the
Poly-ICLC could caused the signiﬁcant increased phosphoryla-
tion levels of p65, TBK1 and IRF3 of TL3 downstream
signaling pathways in macrophage (Table 6), which further
conﬁrm that Poly-ICLC could activate TLR3 downstream
signaling pathways in macrophages.
4. Discussion
A large number of animal experiments and clinical test have
veriﬁed that M2 type TAM can promote the growth, inﬁltration
and migration of tumor, while the M1 type TAM possesses the
effect of promoting immune activation and inhibiting tumor
growth. Therefore, it may be a new breakthrough point for the
future cancer treatment to further explore the transformation
between these two cell types, conﬁrm their signal transductionM1 macrophage polarization induced by Poly-ICLC.
Gene expression Control Poly-ICLC
10 ng/mL 100 ng/mL
M1 type iNOS 1.02 ± 0.02 34.67 ± 5.21* 88.04 ± 18.35**
TNF-a 1.00 ± 0.11 213.16 ± 51.06* 871.81 ± 136.21**
IL-1b 0.98 ± 0.12 371.39 ± 77.14* 572.81 ± 97.41**
M2 type CD206 1.01 ± 0.13 0.42 ± 0.11* 0.35 ± 0.08*
Arg-1 1.04 ± 0.07 0.36 ± 0.17* 0.13 ± 0.11*
Tim-1 0.98 ± 0.05 0.48 ± 0.12* 0.42 ± 0.07*
Compared with the control group, *P < 0.05; **P < 0.01.
Table 6
Phosphorylation of p65, TBK1 and IRF3Poly-ICLC promoted by Poly-
ICLC.
Protein expression Control Poly-ICLC
30 min 60 min
p-p65 1.04 ± 0.01 2.37 ± 0.26* 5.42 ± 0.47**
p-TBK1 0.89 ± 0.21 3.60 ± 0.66* 7.81 ± 1.22**
p-IRF3 0.97 ± 0.15 2.33 ± 0.34* 6.03 ± 1.05**
Compared with the control group, *P < 0.05; **P < 0.01.
Bo Liu et al./Asian Paciﬁc Journal of Tropical Medicine 2016; 9(5): 484–488 487pathways and molecular mechanisms, to alter local neoplasm
M2 macrophages to M1 macrophages polarization through
artiﬁcial means.
Pattern recognition receptors (PPR) plays a key role in the
mutual recognition and function of pathogen-associated mo-
lecular pattern (PAMP) of the host cell surface and
pathogen surface, and in the innate immune response activa-
tion [6]. Then, the TCR is considered as the most important
PPR which can identify a variety of pathogens, activate the
natural immune response, remove viruses or exert the
antitumor effect [7–9]. TLR3 ligand is a double-stranded
RNA which usually does not exist in the mammalian body.
It is the product of viral replication, therefore, it is regarded as
a crucial ‘danger signal’ of inducing the body's natural immune
response.
The Poly (I:C), a dsRNA analog, consists of a ploy (I) and a
ploy (C). The Poly-ICLC is produced by using Poly l lysine and
carboxymethylcellulose to stabilize Poly (I:C) and both them are
the TLR3 agonists. The Poly-ICLC can induce the Th1 cytokine
secretion, such as IL-12, TNF-a, IFN-g, IL-6 and type I inter-
feron [10–12], and induce the expression of chemokines, such as
the expression of CXCL9, CXCL10, MCP1, MIP1-a and MIP1
–b. It is closely associated with the immune cells recruitment
[13]. The patients with glioma tumor treated by a combination
therapy of intramuscular poly-ICLC, radiation and temozolo-
mide, the result showed that Poly-ICLC could improve the effect
of radiation and chemotherapy and had no signiﬁcant toxic and
side effect [14]. The Poly-ICLC can also block immunosup-
pressive molecules signals or other danger signals and then
further improve the results of cancer vaccines. It has been used
as the immunologic adjuvant in the treatment of lymphoma, liver
cancer, colon cancer and leukemia etc., which has achieved a
certain curative effect [15–17]. The result obtained in this study
also showed that the Poly-ICLC could extend the survival
time of mice with brown tumor, inhibit the tumor growth and
had the antitumor effect.
The TLR3 can express in a variety of tissue cells including
epithelial cells, tumor cells and immune cells etc. The previous
study has reported that Poly-ICLC can induce the tumor cell
apoptosis by activating the downstream signaling pathway [18],
while the activation of TLR3 in lymphocyte can induce an
innate immune response [19]. The result showed that the ratio
of Treg in local tumor of mice treated with Poly-ICLC
decreased signiﬁcantly, while, the ratio of CD8+ T cell
increased, which could showed that the immune suppressive
microenvironment of it had been improved. The Poly-ICLC
could caused a increased expression of iNOS (macrophage
phenotype M1 markers) in local tumor and inhibit the expression
of CD206 (M2 markers), which revealed that Poly-ICLC might
have an effect on inducing the M1 polarization of TAM.Through the in vitro cultivation of mouse bone marrow-
derived macrophage and after 24-h proceeding by Poly-ICLC,
the expression of proinﬂammatory factor iNOS, TNF-a and
IL-1b in macrophage signiﬁcantly increased, while the expres-
sion of inhibitory molecules CD206, YM-1 and Arg-1 decreased
notably with that the expression difference was positively
correlated with the concentration of Poly-ICLC, which showed
that Poly-ICLC could directly affect the macrophage and induce
the changes in the state of immune function of macrophage.
Besides, the western blot result revealed that 0.5 and 1 h after
received the stimulation from Poly-ICLC, the phosphorylation
levels of p65, TBK1 and IRF3 of TL3 downstream signaling
pathways in macrophage increased signiﬁcantly, which further
proved that Poly-ICLC could activate TLR3 downstream
signaling pathway in macrophages to cause the M1 polarization.
In conclusion, in the subcutaneous transplantation tumor
models of mice Lewis lung cancer 3LL and C16B10 melanoma
cells, Poly-ICLC can be used as a TLR3 agonist to activate the
downstream signaling pathway, induce the polarization of M1
TAM, improve the local inhibitory tumor microenvironment and
then exert the antitumor effect. Poly-ICLC can effectively acti-
vate the innate immune cells, which has a wide application
prospect in anti-tumor treatment.
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